WGS CIK: 1818331

GeneDx Holdings Corp.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.48
FY22:
0.21
FY23:
0.18
FY24:
0.20
FY25:
0.27
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.07
FY22:
0.28
FY23:
0.24
FY24:
0.22
FY25:
0.26
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.55
FY22:
0.49
FY23:
0.42
FY24:
0.42
FY25:
0.52

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.10
FY22:
0.14
FY23:
0.06
FY24:
0.05
FY25:
0.11
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.06
FY22:
0.09
FY23:
0.13
FY24:
0.12
FY25:
0.11
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.39
FY22:
0.25
FY23:
0.23
FY24:
0.25
FY25:
0.31
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.55
FY22:
0.49
FY23:
0.42
FY24:
0.42
FY25:
0.52

All amounts in billions USD Data source:SEC EDGAR